Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$26.82
00.00%
Last update: 4:00 PM
15 minutes delayed
Comments
Loading...
Overview Rating
Good
Exelixis (NASDAQ:EXEL) Stock Quotes, Forecast and News Summary
Exelixis Stock (NASDAQ: EXEL) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 109.00 / 1.76M |
| Day Range | - - - |
| 52 Wk Range | 18.64 - 27.83 |
| Market Cap | $7.81B |
| P/E Ratio | 23.13 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 61 |
| Short Interest | 5.52% |
| Days to Cover | 7.65 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Exelixis Inc
Sector
Health Care
Industry
Biotechnology
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for can...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Exelixis (EXEL) stock?
You can purchase shares of Exelixis (NASDAQ:EXEL) through any online brokerage.
Who are Exelixis (EXEL) competitors?
Other companies in Exelixis’s space includes: Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), Exact Sciences (NASDAQ:EXAS) and Sarepta Therapeutics (NASDAQ:SRPT).
What is the forecast, or price target, for Exelixis (EXEL) stock?
Exelixis has a consensus price target of $27.80.
What is the current price for Exelixis (EXEL)?
The stock price for Exelixis (NASDAQ: EXEL) is $26.82 last updated September 18, 2024 at 4:00 PM EDT.
Does Exelixis (EXEL) pay a dividend?
There are no upcoming dividends for Exelixis.
When is Exelixis (NASDAQ:EXEL) reporting earnings?
Exelixis’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
Is Exelixis (EXEL) going to split?
There is no upcoming split for Exelixis.
What sector and industry does Exelixis (EXEL) operate in?
Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.